These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 30586161)
1. Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives. Hodowanec AC; Pikis A; Komatsu TE; Sampson MR; Younis IR; O'Rear JJ; Singer ME J Clin Pharmacol; 2019 Jun; 59(6):784-798. PubMed ID: 30586161 [TBL] [Abstract][Full Text] [Related]
2. Antiviral treatment of cytomegalovirus infection. Ahmed A Infect Disord Drug Targets; 2011 Oct; 11(5):475-503. PubMed ID: 21827432 [TBL] [Abstract][Full Text] [Related]
3. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Torres-Madriz G; Boucher HW Clin Infect Dis; 2008 Sep; 47(5):702-11. PubMed ID: 18652557 [TBL] [Abstract][Full Text] [Related]
4. Management of cytomegalovirus infection in solid organ transplantation. Kotton CN Nat Rev Nephrol; 2010 Dec; 6(12):711-21. PubMed ID: 20978468 [TBL] [Abstract][Full Text] [Related]
5. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Boeckh M; Ljungman P Blood; 2009 Jun; 113(23):5711-9. PubMed ID: 19299333 [TBL] [Abstract][Full Text] [Related]
6. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients. Razonable RR Infect Dis Clin North Am; 2013 Jun; 27(2):317-42. PubMed ID: 23714343 [TBL] [Abstract][Full Text] [Related]
8. Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients. Koval CE Infect Dis Clin North Am; 2018 Sep; 32(3):581-597. PubMed ID: 30146024 [TBL] [Abstract][Full Text] [Related]
9. Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients. Imlay HN; Kaul DR Clin Infect Dis; 2021 Jul; 73(1):156-160. PubMed ID: 33197929 [TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of cytomegalovirus infection in organ transplant recipients. Kusne S; Shapiro R; Fung J Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989 [TBL] [Abstract][Full Text] [Related]
11. [Update on the management of cytomegalovirus infection in transplant recipients]. Neofytos D; Van Delden C; Manuel O Rev Med Suisse; 2023 Apr; 19(822):726-730. PubMed ID: 37057854 [TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients. Saullo JL; Miller RA Annu Rev Med; 2023 Jan; 74():89-105. PubMed ID: 36332639 [TBL] [Abstract][Full Text] [Related]
13. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients. Le Page AK; Jager MM; Iwasenko JM; Scott GM; Alain S; Rawlinson WD Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176 [TBL] [Abstract][Full Text] [Related]
14. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Sia IG; Patel R Clin Microbiol Rev; 2000 Jan; 13(1):83-121, table of contents. PubMed ID: 10627493 [TBL] [Abstract][Full Text] [Related]
15. Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status. Servais S; Dumontier N; Biard L; Schnepf N; Resche-Rigon M; Peffault de Latour R; Scieux C; Robin M; Meunier M; Xhaard A; Sicre de Fontbrune F; Le Goff J; Socié G; Simon F; Mazeron MC Clin Microbiol Infect; 2016 Mar; 22(3):289.e1-7. PubMed ID: 26627339 [TBL] [Abstract][Full Text] [Related]
16. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Noble S; Faulds D Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Razonable RR Am J Health Syst Pharm; 2005 Apr; 62(8 Suppl 1):S7-13. PubMed ID: 15821266 [TBL] [Abstract][Full Text] [Related]
19. The development and implementation of stewardship initiatives to optimize the prevention and treatment of cytomegalovirus infection in solid-organ transplant recipients. Jorgenson MR; Descourouez JL; Schulz LT; Goldrosen KA; Rice JP; Redfield RR; Saddler CM; Smith JA; Mandelbrot DA Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1068-1074. PubMed ID: 32456718 [TBL] [Abstract][Full Text] [Related]
20. Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation. Limaye AP; Babu TM; Boeckh M Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33115722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]